IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff

id	oai:ojs.pkp.sfu.ca:article-367
record_format	ojs
institution	FUNDACION UNIVERSITARIA MARIA CANO
thumbnail	https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIAMARIACANO/logo.png
country_str	Colombia
collection	Revista de Investigación e Innovación en Ciencias de la Salud
title	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
spellingShingle	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff Rincón Orozco, Bladimiro Serrano Díaz, Norma Cecilia Meneses Duarte, Ligia Stella Sopó-Rincón, Olga Lucía Serrano-García, Angie Yarlady Suárez Suárez, Diana Paola Salazar Acosta, Isail Quintero-Lesmes, Doris Cristina Colmenares-Mejía, Claudia Carolina Salud ocupacional Neutralizing antibodies Coronavirus infections Vaccine Occupational health Anticuerpos neutralizantes Infecciones por coronavirus Vacuna
title_short	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
title_full	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
title_fullStr	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
title_full_unstemmed	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
title_sort	iga, igm, and igg antibodies and neutralizing activity against sars-cov-2 in a population of colombian healthcare workers and hospital staff
author	Rincón Orozco, Bladimiro Serrano Díaz, Norma Cecilia Meneses Duarte, Ligia Stella Sopó-Rincón, Olga Lucía Serrano-García, Angie Yarlady Suárez Suárez, Diana Paola Salazar Acosta, Isail Quintero-Lesmes, Doris Cristina Colmenares-Mejía, Claudia Carolina
author_facet	Rincón Orozco, Bladimiro Serrano Díaz, Norma Cecilia Meneses Duarte, Ligia Stella Sopó-Rincón, Olga Lucía Serrano-García, Angie Yarlady Suárez Suárez, Diana Paola Salazar Acosta, Isail Quintero-Lesmes, Doris Cristina Colmenares-Mejía, Claudia Carolina
topic	Salud ocupacional Neutralizing antibodies Coronavirus infections Vaccine Occupational health Anticuerpos neutralizantes Infecciones por coronavirus Vacuna
topic_facet	Salud ocupacional Neutralizing antibodies Coronavirus infections Vaccine Occupational health Anticuerpos neutralizantes Infecciones por coronavirus Vacuna
citationvolume	7
citationissue	2
publisher	Fundación Universitaria María Cano
ispartofjournal	Revista de Investigación e Innovación en Ciencias de la Salud
source	https://riics.info/index.php/RCMC/article/view/367
language
format	Article
rights	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Revista de Investigación e Innovación en Ciencias de la Salud - 2025
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2025-02-25
date_accessioned	2025-02-25 00:00:00
date_available	2025-02-25 00:00:00
url	https://riics.info/index.php/RCMC/article/view/367
url_doi	https://doi.org/10.46634/riics.367
eissn	2665-2056
doi	10.46634/riics.367
citationstartpage	1
citationendpage	19
url4_str_mv	https://riics.info/index.php/RCMC/article/download/367/1108
url3_str_mv	https://riics.info/index.php/RCMC/article/download/367/1107
url2_str_mv	https://riics.info/index.php/RCMC/article/download/367/1106
_version_	1833433759529041920
spelling	IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff Artículo de revista Rincón Orozco, Bladimiro 2 7 Serrano Díaz, Norma Cecilia Fundación Universitaria María Cano Revista de Investigación e Innovación en Ciencias de la Salud Journal article Meneses Duarte, Ligia Stella Sopó-Rincón, Olga Lucía Serrano-García, Angie Yarlady Suárez Suárez, Diana Paola Salazar Acosta, Isail Quintero-Lesmes, Doris Cristina Colmenares-Mejía, Claudia Carolina This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. https://riics.info/index.php/RCMC/article/download/367/1108 19 Ministerio de salud y protección social. Anexo Técnico No 1 (Elaborado con base en el Anexo No.1 “Manual para la elaboración de textos normativos-proyectos de decreto y resolución”, adoptado mediante Decreto 1081 de 2015, modificado por Decreto 1609 del mismo año) [Internet]; 2024 [cited 2024 Dec 24]. Available from: https://www.minsalud.gov.co/Anexos_Normatividad_Nuevo/Memoria-justificativa-281420240919120016734.pdf Cheedarla N, Hanna LE. Functional and Protective Role of Neutralizing Antibodies (NAbs) Against Viral Infections. In: Buddolla V, editor. Recent Developments in Applied Microbiology and Biochemistry [Internet]. Cambridge: Academic Press; 2019. p. 83-93. doi: https://doi.org/10.1016/B978-0-12-816328-3.00007-6 Beltrán-Pavez C, Riquelme-Barrios S, Oyarzún-Arrau A, Gaete-Argel A, González-Stegmaier R, Cereceda-Solis K, et al. Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile. Sci Adv [Internet]. 2021;7(7):1-13. doi: https://doi.org/10.1126/sciadv.abe6855 Li X, Liang C, Xiao X. SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration. Vaccines [Internet]. 2021;9(10):1-10. doi: https://doi.org/10.3390/VACCINES9101139 Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med [Internet]. 2021;9(9):999-1009. doi: https://doi.org/10.1016/S2213-2600(21)00220-4 Carrillo J, Izquierdo-Useros N, Ávila-Nieto C, Pradenas E, Clotet B, Blanco J. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem Biophys Res Commun [Internet]. 2021;538:187-91. doi: https://doi.org/10.1016/J.BBRC.2020.10.108 Pang NYL, Pang ASR, Chow VT, Wang DY. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Mil Med Res [Internet]. 2021;8(1):1-17. doi: https://doi.org/10.1186/S40779-021-00342-3 Legros V, Denolly S, Vogrig M, Boson B, Siret E, Rigaill J, et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol [Internet]. 2021;18(2):318-27. doi: https://doi.org/10.1038/s41423-020-00588-2 Edara VV, Hudson WH, Xie X, Ahmed R, Suthar MS. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination. JAMA [Internet]. 2021;325(18):1896-8. doi: https://doi.org/10.1001/JAMA.2021.4388 Shrestha LB, Tedla N, Bull RA. Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants. Front Immunol [Internet]. 2021;12:752003. doi: https://doi.org/10.3389/FIMMU.2021.752003 Sharun K, Tiwari R, Dhama K, Emran TB, Rabaan AA, Mutair AA. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies. Hum Vaccin Immunother [Internet]. 2021;17(10):3491-4. doi: https://doi.org/10.1080/21645515.2021.1923350 Furukawa K, Tjan LH, Kurahashi Y, Sutandhio S, Nishimura M, Arii J, et al. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine. JAMA Netw Open [Internet]. 2022;5(5):e2210780. doi: https://doi.org/10.1001/JAMANETWORKOPEN.2022.10780 Centers for Disease Control and Prevention [Internet]. Atlanta: Centers for Disease Control and Prevention; c2024. SARS-CoV-2 Variant Classifications and Definitions; 2022 Apr 26 [cited 2022 Aug 22]; [about 12 screens]. Available from: https://web.archive.org/web/20220822222151/https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html Harris PA, Taylor R, Minor BL, Elliot V, Fernandez M, O’ Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform [Internet]. 2019;95:103208. doi: https://doi.org/10.1016/j.jbi.2019.103208 Colmenares-Mejía CC, Quintero-Lesmes DC, Salazar Acosta I, Suárez DP, Meneses L, Sopó Rincón OL, et al. Seroprevalence of SARS-CoV-2 Infection among Vaccinated Health Workers and Hospital Staff. Arch Clin Biomed Res [Internet]. 2022;6(2):290-5. doi: https://doi.org/10.26502/acbr.50170244 Serrano NC, Quintero-Lesmes DC, Colmenares-Mejía CC, Salazar Acosta I, Suárez DP, Meneses L, et al. Infección por SARS-CoV-2 y respuesta de anticuerpos a la vacuna BNT162b2 en trabajadores de la salud de primera línea de atención para covid-19. Medicina (B Aires) [Internet]. 2022;44(1):31-9. doi: https://doi.org/10.56050/01205498.1659 AESKU.GROUP. WE TAKE CARE OF YOUR HEALTH [Internet]. Wendelsheim: Aesku Group; c2024 [cited 2022 Aug 22]; [about 2 screens]. Available from: https://www.aesku.com/ DIA.PRO Diagnostic Bioprobes srl. ACE2-RBD Neutralization Assay – ELISA [Internet]. Sesto San Giovanni: Dia.Pro; c2024 [cited 2022 Aug 22]; [about 2 screens]. Available from: https://www.diapro.it/products/ace2-rbd-neutralization-assay-elisa/ Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature [Internet]. 2021;591(7851):639-44. doi: https://doi.org/10.1038/s41586-021-03207-w Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med [Internet]. 2021;27(7):1205-11. doi: https://doi.org/10.1038/s41591-021-01377-8 Rogliani P, Chetta A, Cazzola M, Calzetta L. SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines [Internet]. 2021;9(3):1-18. doi: https://doi.org/10.3390/VACCINES9030227 Tea F, Stella AO, Aggarwal A, Darley DR, Pilli D, Vitale D, et al. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. PLoS Med [Internet]. 2021;18(7):e1003656. doi: https://doi.org/10.1371/JOURNAL.PMED.1003656 Tang MS, Case JB, Franks CE, Chen RE, Anderson NW, Henderson JP, et al. Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Clin Chem [Internet]. 2020;66(12):1538-47. doi: https://doi.org/10.1093/CLINCHEM/HVAA211 Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med [Internet]. 2021;13(577): eabd2223. doi: https://doi.org/10.1126/scitranslmed.abd2223 Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection in humans. Nat Microbiol [Internet]. 2020;5(12):1598-607. doi: https://doi.org/10.1038/s41564-020-00813-8 https://riics.info/index.php/RCMC/article/download/367/1107 1 http://purl.org/coar/resource_type/c_6501 https://riics.info/index.php/RCMC/article/download/367/1106 info:eu-repo/semantics/article https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es http://purl.org/coar/resource_type/c_2df8fbb1 http://purl.org/redcol/resource_type/ART info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Revista de Investigación e Innovación en Ciencias de la Salud - 2025 application/pdf Salud ocupacional Neutralizing antibodies Coronavirus infections Vaccine Occupational health Anticuerpos neutralizantes Infecciones por coronavirus Vacuna 2025-02-25 00:00:00 https://doi.org/10.46634/riics.367 2025-02-25 00:00:00 2025-02-25 text/html text/xml 2665-2056 https://riics.info/index.php/RCMC/article/view/367 10.46634/riics.367 Publication

IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
.